NCT02927444View on ClinicalTrials.gov

Immunogenicity and Safety Study of NBP606 in Healthy Toddlers

PHASE3CompletedINTERVENTIONAL
Enrollment

462

Participants

Timeline

Start Date

November 4, 2015

Primary Completion Date

October 26, 2017

Study Completion Date

October 26, 2017

Conditions
Pneumococcal Infections
Interventions
BIOLOGICAL

NBP606

A single intramuscular injection into the thigh

BIOLOGICAL

Prevnar13

A single intramuscular injection into the thigh

Trial Locations (1)

Unknown

Clinical Research Center, Seoul

All Listed Sponsors
lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT02927444 - Immunogenicity and Safety Study of NBP606 in Healthy Toddlers | Biotech Hunter | Biotech Hunter